Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06964347 · ClinicalTrials.gov registry record · NA
Combined Local Anesthetic Blockade and Neuromodulation vs Local Anesthetic Blockade Only for Analgesia After Below-knee Amputation: RCT
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT06964347: Clinical Trial NA study, sponsored by Stanford University.
NCT06964347 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06964347, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This multi-site clinical trial aims to assess the efficacy and safety of combining peripheral nerve stimulation with local anesthetic nerve blockade compared to the standard of care, i.e., local anesthetic blockade only using safe stimulation parameters in a condition associated with high postoperative pain state, i.e. a patient undergoing lower limb amputation.
Interventions
- DRUG Ropivacaine 0.2%
- DEVICE Ropivacaine 0.2% + nerve stimulator set
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2025-12 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06964347
The ClinicalTrials.gov registry entry for NCT06964347 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine 0.2% is the first listed.
NCT06964347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06964347 about?
NCT06964347 is a clinical study titled "Combined Local Anesthetic Blockade and Neuromodulation vs Local Anesthetic Blockade Only for Analgesia After Below-knee Amputation: RCT". This multi-site clinical trial aims to assess the efficacy and safety of combining peripheral nerve stimulation with local anesthetic nerve blockade compared to the standard of care, i.e., local anesthetic blockade only using safe stimulation parameters in a condition associated with high postoperat...
What is the current status of trial NCT06964347?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2025-12. Estimated completion is 2026-12.
What interventions are being tested in trial NCT06964347?
The interventions under investigation include: Ropivacaine 0.2% (DRUG), Ropivacaine 0.2% + nerve stimulator set (DEVICE).
Who is sponsoring clinical trial NCT06964347?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.